GenrAb, Inc.
PrivateLast Round
Seed
Apr 22, 2025
Total Funding Raised
$5.6M
Company Overview
GenrAb, Inc. operates in Healthcare & Life Sciences and is based in Dallas, Texas. Its latest recorded funding round was a Seed round in April 2025.
GenrAb, Inc. is a biotechnology company that develops neuroprotective therapies by harnessing the human immune system to identify fully-human monoclonal antibodies for the treatment of neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenrAb, Inc. Comparables
Compare GenrAb, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alchemab Therapeutics | 79% | |
| Nura Bio | 76% | |
| Sanofi | 72% |
For institutional investors. Book with your work email.
GenrAb, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
GenrAb, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Actium Group | Seed |
| Salem Partners | Seed |
| Research Bridge Partners | Seed |
| JMS Capital | Seed |
| Green Park & Golf Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2025
Developing therapy to protect brain cells under stress, potentially treating MS and ALS.
- Apr 22, 2025
$6M round led by Actium Group
For institutional investors. Book with your work email.
GenrAb, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GenrAb, Inc.'s valuation, stock price, and market status.
Is GenrAb, Inc. a public or private company?
GenrAb, Inc. is a private company.
What is the current stock price of GenrAb, Inc.?
GenrAb, Inc. is a private company, so its shares have no public market price. Caplight tracks GenrAb, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GenrAb, Inc. worth (valuation)?
Valuation information for GenrAb, Inc. is not publicly available.
Can I buy GenrAb, Inc. stock?
GenrAb, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GenrAb, Inc.'s last funding round?
GenrAb, Inc.'s most recent funding round was Seed on April 22, 2025.
Who are the main investors in GenrAb, Inc.?
Key investors in GenrAb, Inc. include Actium Group.
Will GenrAb, Inc. IPO soon?
No public IPO plans have been announced for GenrAb, Inc..
How can I track GenrAb, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in GenrAb, Inc.'s shares on secondary markets.